Latest BBS-Bioactive Bone Substitutes News & Updates

See the latest news and media coverage for BBS. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
BBS-Bioactive Bone Substitutes (BBS)

Developer of bioactive bone graft substitutes

bbs-artebone.fi
Headquarters
Oulu, Finland
Founded year
2003
Company type
Private company
Number of employees
10–50

Last updated

Latest news about BBS-Bioactive Bone Substitutes (BBS)

In short: BBS faced severe financial distress, leading to the termination of CEO Juliusz Rakowski's agreement and an eventual declaration of bankruptcy.

Company announcements

BBS

BBS announces 2025 financial calendar

Financial statements release on February 21, annual report in March, half-year report on August 29. AGM on April 29. Silent period precedes reports.

BBS

BBS announces CEO Juliusz Rakowski terminates agreement

Rakowski continues until February 28, 2025. He expresses gratitude to the Board, shareholders, partners, and employees.

Unlock all announcements with a

Media coverage

London Stock Exchange

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd BBS-Bioactive Bone Substitutes Plc ("BBS...

Unlock all articles with a

Never miss news about BBS

Track BBS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BBS competitors & trending companies

Browse news for competitors to BBS and other trending companies.